Search
In June, the New Jersey Assembly passed A-5037, a bill that increases penalties for those who create, distribute or administer counterfeit, adulterated or misbranded medical drugs and devices. The legislation, which has been sent to the New Jersey Senate’s Budget and Appropriations Committee, would make the sale of more than 100 units of fake medicine punishable by a sentence of five to ten years, a fine of up to $150,000, or both.
Read MoreThis editorial by Adam Fein and Dirk Rodgers was published in Stat News on July 11, 2019. In it, Fein and Rodgers warn that plans by states to create drug importation programs will open new pathways for counterfeit drugs to enter the U.S. drug supply chain…
Read More
A series of eight different busts in Arizona this month has yielded approximately 132,000 counterfeit pills made with fentanyl, with seizures happening all across the Grand Canyon state.
Read More
This editorial by retired DEA agent Douglas Hebert was published in The Arizona Capital Times ,on June 27, 2019. In it, Hebert explains how drug importation programs will help organized crime expand their $200 billion-a-year counterfeit pharmaceutical industry into the U.S., at the expense of Americans.
Read More
On June 24, 2019, the National Alliance of State Pharmacy Associations (NASPA), along with the American Pharmacists Association (APhA), and the National Association of Chain Drug Stores (NACDS) wrote a joint letter to U.S. Health and Human Services (HSS) Secretary Alex Azar questioning the wisdom of poorly thought-out importation proposals.
Read More
Drug Importation in Vermont: An Overview Synopsis: In May 2018, the Governor of Vermont signed S 175, a bill which directs the Agency of Human Services to design a program for wholesale importation of prescription drugs into Vermont from Canada that complies with federal requirements. Under the Medicare Modernization Act of 2003, Vermont is required to submit a plan to…
Read More
In this editorial, which was published in Crain’s New York Business on June 19, 2019, Canadian law enforcement veteran Don Bell explains that the New York Legislature’s effort to establish a wholesale prescription drug importation program, is “a gigantic loophole that criminals will pounce on to traffic counterfeit drugs into the state.”
Read More
In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”
Read More
On June 4, 2019, Laval police conducted a series of raids to bring down the ring that was making the counterfeit pills. 235 police officers searched 13 locations in Laval, Montreal and the communities that ring the north shore of Laval and Montreal islands. The raids have resulted in the arrest of eleven people.
Read More
On June 7, 2019, a federal jury found Dion Gregory Fisher, 33, of Seminole, FL, guilty of conspiring to manufacture and distribute fentanyl and fentanyl analogue, guilty of five counts of fentanyl distribution and manufacturing and eight counts of committing money laundering transactions involving more than $10,000 of narcotics proceeds.
Read More